Hospital activity before and after diagnosis of monoclonal gammopathy of undetermined significance (MGUS)

Research output: Contribution to journalMeeting abstractpeer-review


Monoclonal gammopathy of undetermined significance (MGUS; ICD-O-3=9761/1) is a premalignant clonal disorder that progresses to myeloma at ~1% per year. Whilst MGUS is often diagnosed incidentally and other symptoms of myeloma are absent, several follow-up studies have reported relationships with co-morbidities and poor survival. Illness patterns before MGUS diagnoses have, however, not been examined in relation to those seen after diagnosis. Here we compare hospital activity of people with MGUS and patients with mature B-cell malignancies to that in the general population.
Original languageEnglish
Article number37
JournalBritish journal of cancer
Early online date4 Oct 2019
Publication statusPublished - 28 Oct 2019
EventThe National Cancer Research Institute (NCRI) Cancer Conference 2019 - Glasgow, United Kingdom
Duration: 3 Nov 20195 Nov 2019

Bibliographical note

If any changes are made to this PURE entry can you please inform
Selected Abstracts from the 2019 NCRI Cancer Conference of National Cancer Research Institute

Cite this